The IL6R variation Asp358Ala is a potential modifier of lung function in subjects with asthma
Authors:
- Gregory A. HawkinsGHGregory A. Hawkins
- William W. BusseWBWilliam W. Busse
- Serpil C. ErzurumSESerpil C. Erzurum
- Sally E. WenzelSWSally E. Wenzel
- 1 August 2012
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 130 (2) , 510-515.e1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Identification of IL6R and chromosome 11q13.5 as risk loci for asthmaThe Lancet, 2011
- Importance of hedgehog interacting protein and other lung function genes in asthmaJournal of Allergy and Clinical Immunology, 2011
- Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonistsJoint Bone Spine, 2010
- Tocilizumab (Actemra) for rheumatoid arthritis.2010
- Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica: Figure 1.The Journal of Rheumatology, 2010
- Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel DiseaseCurrent Pharmaceutical Design, 2009
- Ethnic differences in asthma and associated phenotypes: Collaborative Study on the Genetics of AsthmaJournal of Allergy and Clinical Immunology, 2001
- The soluble interleukin 6 receptor: mechanisms of production and implications in diseaseThe FASEB Journal, 2001
- Proceedings of the ATS Workshop on Refractory AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000